LeMaitre Vascular, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M | $17.9M | $22.9M |
| Depreciation & Amortization | $10.4M | $9.6M | $9.5M | $9.4M | $11.1M | $8.4M | $5.4M | $4.3M |
| Depreciation | $4.8M | $3.8M | $3.4M | $3.3M | $3.3M | $3.2M | $3.0M | $2.6M |
| Amortization | $5.6M | $5.8M | $6.1M | $6.2M | $6.2M | $5.0M | $2.4M | $1.8M |
| Stock-Based Compensation | $7.8M | $6.6M | $5.3M | $4.2M | $3.5M | $3.0M | $2.6M | $2.3M |
| Net Cash from Operating Activities | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M | $34.8M | $14.2M | $19.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $6.8M | $7.0M | $7.3M | $3.2M | $4.9M | $3.0M | $3.8M | $3.1M |
| Business Acquisitions | $1.9M | $0 | $899.0K | $0 | $0 | $72.6M | $21.2M | $12.3M |
| Net Cash from Investing Activities | $-64.9M | $-200.1M | $-24.7M | $-10.4M | $-61.1M | $-52.9M | $-24.1M | $-7.1M |
| Financing Activities | ||||||||
| Dividends Paid | $18.1M | $14.4M | $12.4M | $11.0M | $9.3M | $7.7M | $6.7M | $5.4M |
| Stock Repurchases | $1.8M | $1.7M | $853.0K | $642.0K | $802.0K | $570.0K | $683.0K | $741.0K |
| Net Cash from Financing Activities | $-14.5M | $158.1M | $-7.1M | $-9.2M | $13.7M | $32.2M | $-4.6M | $-4.4M |
| Net Change in Cash | $2.6M | $1.3M | $5.1M | $5.3M | $-12.9M | $15.0M | $-14.5M | $7.2M |
| Free Cash Flow | $74.5M | $37.2M | $29.5M | $22.1M | $30.2M | $31.8M | $10.4M | $16.5M |